1. 111OMechanism informs precision: In vivo determinants of response to anti-CTLA-4 antibodies. (16th September 2018) Authors: Furness, A J S; Arce Vargas, F; Litchfield, K; Rosenthal, R; Gore, M; Larkin, J; Turajlic, S; Swanton, C; Peggs, K; Quezada, S Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1836PDRepresentative sequencing: Profiling extreme tumor diversity. (23rd October 2018) Authors: Litchfield, K; Au, L; Swanton, C; Turajlic, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 7OContrasting the drivers of response to immunotherapy across solid tumour types: Results from analysis of > 1000 cases. (7th November 2019) Authors: Litchfield, K; Swanton, C; Turajlic, S; McGranahan, N; Quezada, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First report of overall survival for ipilimumab plus nivolumab from the phase III Checkmate 067 study in advanced melanoma. (19th January 2018) Authors: Turajlic, S; Gore, M; Larkin, J Journal: Annals of oncology Issue: Volume 29:Number 3(2018) Page Start: 542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PWE-085 Immune checkpoint inhibitor induced acute liver injury – a national cohort study. (8th June 2018) Authors: Nathwani, Rooshi; Au, L; Barlow, C; Tillett, T; Bowen, R; Spain, L; Thomas, J; Backhouse, M; Gurung, A; Morrison, R; Cross, T; Herbert, C; Goldin, R; Gore, M; Larkin, J; Turajlic, S; Antoniades, C Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Searching for the needle in the haystack: deconvoluting the evolutionary dynamics of residual disease in human glioblastoma. (7th February 2019) Authors: Shepherd, S T C; Litchfield, K; Turajlic, S Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. WHO 2022 classification of penile and scrotal cancers: updates and evolution. Issue 4 (9th November 2022) Authors: Menon, S; Moch, H; Berney, DM; Cree, IA; Srigley, JR; Tsuzuki, T; Compérat, E; Hartmann, A; Netto, G; Rubin, MA; Gill, AJ; Turajlic, S; Tan, PH; Raspollini, MR; Tickoo, SK; Amin, M B Journal: Histopathology Issue: Volume 82:Issue 4(2023) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗